A kind of bursal heptapeptide for promoting vaccine immune response and its application
A technology of bursa polypeptide and bursa, which is applied in the field of bursa active heptapeptide, can solve problems such as economic losses in poultry industry, hidden dangers of public health safety, threats to human health, etc., to promote extensive immune enhancement and simple structure , Improving the effect of vaccine immunity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] 1. Isolation and identification of BP7
[0028] Wash 500 g of AA broiler bursa tissues without fascia and adipose tissue once with 0.85% physiological saline (precooled to 4-10° C.). After draining, place the bursa tissue in a tissue masher, add pre-cooled saline, and homogenize at high speed three times, 30 seconds each time, and keep the homogenization process at 0-10°C. Then, the homogenate was ultrasonically lysed twice at 4°C, 5 min each time. Then the lysate was heated to 80°C, kept warm for 5min, then quickly placed on ice, and cooled to 10°C. The lysate was then refrigerated and centrifuged for 30 minutes (4000×g / min). The supernatant was collected and freeze-thawed twice. Then the supernatant was centrifuged at high speed at 12000g / min, 4°C, 30min. The supernatant was collected for ultrafiltration, and the ultrafiltrate with a molecular weight below 1000 Da was collected, that is, the crude extract of the bursa tissue. After freeze-drying, dilute with ultr...
Embodiment 2
[0030] 1. Synthetic BP7
[0031] A commercial peptide synthesis company is entrusted to synthesize the peptide according to the GGCDGAA sequence (SEQ ID No.1), and the purity is required to be ≥ 97%.
[0032] 2. Vaccines
[0033] AIV inactivated vaccine (purchased from Nanjing Tianbang Biotechnology Co., Ltd.)
[0034] 3. Grouping of experimental animals
[0035] BALB / C mice are randomly divided into five groups, 10 in every group: (I) PBS control group (every immunization 0.2ml PBS); (II) AIV inactivated vaccine immunization group (every immunization inactivated vaccine 0.2ml ); (III~V) inactivated vaccine+BP7 group (BP7 concentrations were 10, 50, 250ug / mL, and the immunization dose was 0.2ml); the mice in the corresponding group were immunized twice by intraperitoneal injection. The immunization interval was two weeks, 200ul / each / every time (Table 1).
[0036] 4. Sample Collection of Immunized Mice
[0037] After the third immunization, blood was collected from the orb...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com